{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:40:49Z","timestamp":1792726849340,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.yebeh.2026.111350","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:21:05Z","timestamp":1792718465000},"page":"111350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical implications of Brivaracetam Cross-Reactivity with levetiracetam immunoassay"],"prefix":"10.1016","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0189-7011","authenticated-orcid":false,"given":"Aline","family":"Herlopian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumbhojkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanth","family":"Tallapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikol","family":"Aghadzhanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Alsherbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohith","family":"Nelakurthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Mattson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2026.111350_b0005","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419873518","article-title":"\u201cLevetiracetam and brivaracetam: a review of evidence from clinical trials and clinical experience,\u201d (in eng)","volume":"12","author":"Steinhoff","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.yebeh.2026.111350_b0010","doi-asserted-by":"crossref","unstructured":"A. Mittal et al., \u201cMechanisms underlying allosteric modulation of antiseizure medication binding to synaptic vesicle protein 2A (SV2A),\u201d (in eng), Proc. Natl. Acad. Sci. U. S. A., vol. 122, no. 36, p. e2510239122, Sep 9 2025, doi: 10.1073\/pnas.2510239122.","DOI":"10.1073\/pnas.2510239122"},{"issue":"2","key":"10.1016\/j.yebeh.2026.111350_b0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/epi.13638","article-title":"\u201cEvidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein,\u201d (in eng)","volume":"58","author":"Wood","year":"2017","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.yebeh.2026.111350_b0020","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.5858\/arpa.2020-0562-CP","article-title":"\u201cTherapeutic Drug monitoring of Second- and Third-Generation Antiepileptic Drugs,\u201d (in eng)","volume":"145","author":"Krasowski","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.yebeh.2026.111350_b0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.seizure.2021.11.026","article-title":"Crossreactivity in antiepileptic drug monitoring: Reply to: Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy-a monocenter survey","volume":"94","author":"Strasser","year":"2022","journal-title":"Seizure - European Journal of Epilepsy"},{"key":"10.1016\/j.yebeh.2026.111350_b0030","article-title":"\u201cOvernight switch from levetiracetam to brivaracetam. Safety and tolerability,\u201d (in eng)","volume":"16","author":"Abraira","year":"2021","journal-title":"Epilepsy Behav Rep"},{"issue":"6","key":"10.1016\/j.yebeh.2026.111350_b0035","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/epi4.13078","article-title":"\u201cBRIVA-ONE study: 12-month outcomes of brivaracetam monotherapy in clinical practice,\u201d (in eng)","volume":"9","author":"Villanueva","year":"2024","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2026.111350_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2019.106218","article-title":"\u201cPharmacokinetic interaction of brivaracetam on other antiepileptic drugs in adults with focal seizures: Pooled analysis of data from randomized clinical trials,\u201d (in eng)","volume":"158","author":"Moseley","year":"2019","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2026.111350_b0045","doi-asserted-by":"crossref","unstructured":"T. Seki et al., \u201cElectronic Health Record-Nested Reminders for Serum Lithium Level Monitoring in Patients With Mood Disorder: Randomized Controlled Trial,\u201d (in eng), J Med Internet Res, vol. 25, p. e40595, Mar 22 2023, doi: 10.2196\/40595.","DOI":"10.2196\/40595"},{"issue":"1","key":"10.1016\/j.yebeh.2026.111350_b0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14581\/jer.24003","article-title":"\u201cMedication Reconciliation Errors on Discharge for Epilepsy monitoring Unit patients,\u201d (in eng)","volume":"14","author":"Alboudi","year":"2024","journal-title":"J Epilepsy Res"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026004713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026004713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:27:56Z","timestamp":1792726076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505026004713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":10,"alternative-id":["S1525505026004713"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111350","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical implications of Brivaracetam Cross-Reactivity with levetiracetam immunoassay","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111350"}}